TAKEDA PHARMACEUTIC-SP ADR (TAK) Stock Institutional Trading Activity
TAKEDA PHARMACEUTIC-SP ADR (TAK) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Hancock Classic Value, Sequoia Financial Advisors, Causeway Capital Management, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.
Explore more:
- TAKEDA PHARMACEUTIC-SP ADR (TAK) stock institutional ownership
- TAKEDA PHARMACEUTIC-SP ADR (TAK) stock insider trading activity
- Stock rankings
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q3 2020 | Causeway Capital Management | Sell | -61,855 | 1,478,524 | $26,377 |
| Q3 2020 | Renaissance Technologies LLC | Buy | 129,007 | 5,736,707 | $102,343 |
| Q2 2020 | Causeway Capital Management | Sell | -632,986 | 1,540,379 | $27,619 |
| Q2 2020 | Renaissance Technologies LLC | Buy | 1,844,300 | 5,607,700 | $100,546 |
| Q1 2020 | Causeway Capital Management | Sell | -328,931 | 2,173,365 | $32,992 |
| Q1 2020 | Renaissance Technologies LLC | Buy | 1,755,211 | 3,763,400 | $57,128 |
| Q4 2019 | Renaissance Technologies LLC | Buy | 303,789 | 2,008,189 | $39,622 |
| Q4 2019 | Causeway Capital Management | Sell | -26,204 | 2,502,296 | $49,370 |
| Q3 2019 | Renaissance Technologies LLC | Buy | 930,600 | 1,704,400 | $29,316 |
| Q3 2019 | Causeway Capital Management | Sell | -19,240 | 2,528,500 | $43,490 |
| Q3 2019 | Baupost Group | Sell | -3,200 | 9,434,803 | $162,279 |
| Q2 2019 | Renaissance Technologies LLC | Buy | 773,800 | 773,800 | $13,696 |
| Q2 2019 | Causeway Capital Management | Buy | 159,387 | 2,547,740 | $45,095 |
| Q2 2019 | Baupost Group | Sell | -1,231,018 | 9,438,003 | $167,053 |
| Q1 2019 | Causeway Capital Management | Buy | 183,969 | 2,388,353 | $48,651 |
| Q1 2019 | Baupost Group | Buy | 10,669,021 | 10,669,021 | $217,328 |
| Q4 2018 | Causeway Capital Management | Buy | 2,204,384 | 2,204,384 | $37,078 |
Frequently asked questions about TAK activity
Which institutional owners are buying TAK?
Institutional owners buying TAK include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TAK activity?
"Buy" means an investor increased their reported position in TAK compared to the prior reporting period. This reflects growing exposure to TAKEDA PHARMACEUTIC-SP ADR (TAK) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TAK increasing?
Institutional interest in TAK can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.